ON ANTIBIOTICS

Upcoming and Past meetings of the APPG on Antibiotics

Upcoming meetings

Past meetings

The existential threat of drug-resistant infections: how accurate are death certificates?

20 February 2023

Report launch: An inquiry into the links between antibiotic resistance and inadequate water, sanitation and hygiene facilities in healthcare settings across the world’s least developed countries

6 December 2022

APPG on Antibiotics Annual General Meeting / Setting the agenda for 2023

1 November 2022

Second Oral Evidence Session: An inquiry into the links between antibiotic resistance and lack of access to clean water, sanitation and hygiene facilities, in healthcare settings across the world’s least developed countries

19 October 2022

First Oral Evidence Session: An inquiry into the links between antibiotic resistance and lack of access to clean water, sanitation and hygiene facilities, in healthcare settings across the world’s least developed countries

25 January 2022

APPG on Antibiotics Annual General Meeting / Setting the agenda for 2022

Pandemic prevention & preparedness: how should the COVID response aid efforts to contain & control antimicrobial resistance?

24 November 2020

Antibiotic residues in sewage and agricultural run-off: can we determine safe thresholds to combat deadly superbugs?

29 September 2020

Inaugural Meeting of the APPG on Antibiotics

What can primary care professionals do to help ‘contain & control’ antibiotic resistance in the UK?

26 February 2019

Vaccines to tackle drug-resistant infections: an evaluation of R&D opportunities

13 November 2018

APPG on Antibiotics Annual General Meeting / How close are we to meeting the urgent need for new antibiotics?

27 February 2018

How to incentivise the development of antibiotics: lessons from malaria drug research partnerships

Impact of antimicrobial resistant Salmonella infections and malaria upon treatment

30 November 2016

Discovery, Research and Development of New Antibiotics

Podcasts available

APPG on Antibiotics Annual General Meeting

The Review on Antimicrobial Resistance and how the NHS and Pharmaceutical industry are responding to the UK Strategy on AMR

Podcasts available

APPG-A Annual General Meeting

22 October 2014

Educating people to use antibiotics properly

22 October 2014

Presentation October 2014: The public views on and use of antibiotics and changing them: Dr Cliodna McNulty, Head, Public Health England Primary Care Unit

22 October 2014

Presentation October 2014: What can be done to maintain antibiotic effectiveness? Addressing prescribing behaviours. Professor Alison Holmes, Imperial College, London

Antibiotic use in animals, should we be worried?

APPG-A Annual General Meeting

Presentation June 2014: Animal Use and Selection of Antibiotic Resistant Bacteria – Antibiotic Use in Animals Part 2: Peter Jones, Past President BVA.

Presentation June 2014: Antibiotic Resistance in Bacteria from Animals Part 2: Christopher Teale, AHVLA.

Presentation March 2014: Animal Use and Selection of Antibiotic Resistant Bacteria – Antibiotic Use in Animals: Peter Jones, Past President BVA.

Presentation March 2014: Antibiotic Resistance in Bacteria from Animals: Christopher Teale, AHVLA.

23 October 2013

Meeting the Antibiotic Challenge: The 2013-18 UK Strategy on Antibiotics

BSAC represents one of the world’s most influential networks of infection specialists (including, but not limited to, infectious disease physicians, microbiologists, pharmacists, researchers, and nurses).

As a learned society and charity, its mission is to work with others to provide high-quality open access support to those who need it most. This support takes many forms: free membership, workshops, conferences, public and political engagement, educational resources, professional fora, research grants, and research publications via the Journal of Antimicrobial Chemotherapy, and the online open access journal, JAC-Antimicrobial Resistance.

In recent years, the Society has worked in many countries, with many partners (from development banks and other professional societies, to government departments and supranational bodies like the World Health Organization) to help contain and control the growing threat of drug-resistant infection that has arisen as a consequence of antimicrobial resistance.

BSAC possesses almost 50 years of experience in leading on infection education, surveillance, and research. Dedicated to saving lives through the appropriate use and development of therapies (especially antibiotics), it supports thousands of scientists, healthcare professionals, and policymakers, across the world every year through its activities

Superbugs - the drug-resistant microbes that cause infections that are difficult, and sometimes impossible to treat - pose an existential threat. Every year, they contribute to the death of about 5 million people. And the situation is getting worse. The good news is, we can stop them. By supporting local projects, we can make a practical difference to communities most at risk.

Stop Superbugs is a global health initiative from BSAC. It connects people who need support with people who want to give support - wherever they are in the world

Note: This is not an official website of the House of Commons or the House of Lords. It has not been approved by either House or its committees.
All-Party Parliamentary Groups are informal groups of Members of both Houses with a common interest in particular issues.
The views expressed in these web pages are those of the group.

The British Society for Antimicrobial Chemotherapy (BSAC) © 2011 Registered Charity 1093118.
Registered as a company limited by guarantee in England & Wales No: 4443910.

© 2017

Top